| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.95B | +96.7% | +251.0% |
| Cost of Revenue | $1.29B | -13.2% | -1.9% |
| Gross Profit | $4.66B | +202.5% | +1120.4% |
| R&D Expense | $337.0M | +3.1% | +18.2% |
| SG&A Expense | $161.0M | +15.8% | +15.8% |
| Operating Income | $4.11B | +286.0% | +318.6% |
| Pre-tax Income | $4.11B | +338.3% | +316.0% |
| Income Tax | $492.0M | +267.2% | +1437.5% |
| Net Income | $3.62B | +350.2% | +287.0% |
| EPS (Basic) | $24.43 | +347.4% | +283.3% |
| EPS (Diluted) | $23.03 | +347.2% | +272.8% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.73B | +142.7% | +147.8% |
| Accounts Receivable | $2.73B | +120.0% | +178.4% |
| Inventory | $2.24B | +13.6% | +3.6% |
| Current Assets | $9.17B | +78.0% | +80.1% |
| Total Assets | $17.07B | +31.4% | +31.8% |
| Current Liabilities | $1.92B |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.54B | — | — |
| Capital Expenditures | $134.0M | — | — |
| Investing Cash Flow | -$263.0M | — | — |
| Financing Cash Flow | -$2.02B | — | — |
| Free Cash Flow | $4.41B | — | — |
| +39.4% |
| Long-term Debt | $0 | -100.0% | -100.0% |
| Total Liabilities | $3.30B | +18.4% | -13.2% |
| Stockholders' Equity | $13.78B | +34.9% | +50.4% |